Puerto Rico Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 9, 2025

December 9, 2025

RTI to Showcase Connext Drive 4.0 at CES 2026

GlobeNewswire

December 9, 2025

GigaCloud Technology Inc Expands Fulfillment Network with New Facility in New Jersey

GlobeNewswire

December 9, 2025

New York Gastroenterology Associates Taps Proscia for Digital Pathology

GlobeNewswire

December 9, 2025

zSpace Showcases Major Expansion of CTE AR/VR Learning Applications at ACTE CareerTech VISION 2025

GlobeNewswire

December 9, 2025

AskBio’s AB-1005 and AB-1002 Receive Pioneering Regenerative Medical Product Designation in Japan

GlobeNewswire

December 9, 2025

ORYZON Presents Data for Iadademstat Combinations in AML at the American Society of Hematology (ASH) 67th Annual Meeting

GlobeNewswire

December 9, 2025

ZenaTech Enters UK Market Closing Drone-as-a-Service Acquisition of Casado Design Ltd., Expanding to the Growing Telecom Tower Design and Infrastructure Sector

GlobeNewswire

December 9, 2025

Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants

GlobeNewswire

December 9, 2025

BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

GlobeNewswire

December 9, 2025

Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company

GlobeNewswire

December 9, 2025

Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada

GlobeNewswire

December 9, 2025

Digital Culture Group Dominates Awards Season With Wins in AI Innovation

GlobeNewswire

December 9, 2025

Erste Ergebnisse aus BioNTechs und BMS’ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig zeigten ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem dreifach negativem Brustkrebs

GlobeNewswire

December 9, 2025

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

GlobeNewswire

December 9, 2025

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science

GlobeNewswire

December 9, 2025

ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science

GlobeNewswire

December 9, 2025

Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma

GlobeNewswire

December 9, 2025

Aeluma Files New Patent That Enhances Intellectual Property for Large-Scale High Performance Semiconductor Manufacturing

GlobeNewswire

December 9, 2025

Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease

GlobeNewswire

December 9, 2025

SailPoint Announces Fiscal Third Quarter 2026 Results

GlobeNewswire